What is prehypertension and what can you do about it? References

References

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157:2413. [Abstract]
2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206. [Full text]
3. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: new challenges of the old problem. Arch Intern Med. 2004; 164:2126. [Full text]
4. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004; 164:2113. [Full text]
5. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS Data Brief no 3. Hyattsville, MD: National Center for Health Statistics; 2008. [Full text]
6. Robinson SC, Brucer M. Range of normal blood pressure: a statistical and clinical study of 11,383 persons. Arch Int Med. 1939; 64:409.
7. Franklin SS, Pio JR, Wong ND, et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005; 111:1121. [Full text]
8. Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens. 2009; 27:243. [Abstract]
9. Julius S, Nesbitt S, Egan B, et al; TROPHY study group. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004; 44:146. [Full text]
10. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001; 345:1291. [Full text]
11. Qureshi AI, Suri FK, Kirmani JF, et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005; 36:1859. [Full text]
12. Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007; 115:855. [Full text]
13. Julius S, Nesbitt SD, Egan BM, et al; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354:1685. [Full text]
14. King DE, Egan BM, Mainous AG 3rd, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004; 6:562. [Abstract]
15. Chrysohoou C, Pitsavos C, Panagiotakos DB, et al. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens. 2004; 17:568. [Abstract]
16. Lewington S, Clarke R, Qizilbash N, et al; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360:1903. [Abstract]
17. Parikh NI, Pencina MJ, Wang TJ, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008; 148:102. [Abstract]
18. Appel LJ, Moore TJ, Obarzanek E, et al; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997; 336:1117. [Full text]
19. Appel LJ, Champagne CM, Harsha DW, et al; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289:2083. [Full text]
20. Player MS, King DE, Mainous AG 3rd, Geesey ME. Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med. 2007; 5:403. [Full text]
21. Flack JM, Sica DA, Bakris G, et al; on behalf of International Society of Hypertension in Blacks. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010; 56:780. [Abstract]
22. Lüders S, Schrader J, Berger J, et al; PHARAO Study Group. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008; 26:1487. [Abstract]
23. National Institutes of Health. NIH launches multicenter clinical trial to test blood pressure strategy [news release]. November 26, 2010.
24. Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials.gov Identifier: Clinical Trial identifier NCT01206062.. [Clinical Trial] Accessed December 16, 2010.